Pharmaceuticals, Biotechnology and Life Sciences
AstraZeneca ob Tuesday announced the appointment of Sheri McCoy and Deborah DiSanzo as Non-Executive Directors of the company. McCoy will also become a member of the Audit Committee.
TiGenix NV has obtained a license for the commercial production of expanded adipose-derived stem cells (eASCs) at its expanded manufacturing facility in Madrid.
Novartis on Tuesday announced positive results from the Phase III PARADIGMS study, investigating the safety and efficacy of oral once-daily…
Biocartis Group got clearance for the Idylla Respiratory (IFV-RSV) Panel from the US Food and Drug Administration (FDA). Idylla Respiratory…
Joseph Jimenez, Chief Executive Officer (CEO) of Novartis, step down as CEO in 2018, after eight years in position. To…
Global Vaccines Market to reach US$ 60 Billion by the year 2022. Pediatric vaccines market is having a dominant market share compared…
Amgen posted positive results from a post-hoc analysis requested by the U.S. Food and Drug Administration (FDA) of the Phase 3 head-to-head ENDEAVOR trial, which followed patients for at least three years after enrollment.
Norwegian pharmaceutical company Vistin Pharma ASA said it had strong demand and stable prices for its metformin products in the…
Biocartis Group NV has published two study abstracts about the performance of its new set of biomarkers for microsatellite instability…
Santhera Pharmaceuticals has been cleared in Israel for Raxone (idebenone) for visual impairment in adolescents and older, with Leber’s hereditary optic neuropathy (LHON).